Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 222

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer

Open access
Ruan, Guo-Tian, Xie, Hai-Lun, Zhang, He-Yang, Liu, Chen-An, Ge, Yi-Zhong, Zhang, Qi, Wang, Zi-Wen, Zhang, Xi, Tang, Meng, Song, Meng-Meng, Zhang, Xiao-Wei, Yang, Ming, Chen, Yong-Bing, Yu, Kai-Ying, Deng, Li, Gong, Yi-Zhen, Hu, Wen, Wang, Kun-Hua, Cong, Ming-Hua, Shi, Han-Ping·2022·Frontiers in Endocrinology

Abstract

Background: Systemic inflammation and insulin resistance (IR) are closely related in patients with cancer. However, there is no relevant indicator that combines inflammation and IR to predict patient prognosis. Therefore, this study aimed to develop and validate a novel inflammation- and IR-related marker in patients with cancer. Methods: The total cohort of this study included 5221 patients with cancer, and the training and validation cohorts were randomized in a 7:3 ratio. C-reactive protein (CRP) and fasting triglyceride glucose (TyG) were used to reflect patients’ inflammation and IR status, respectively. The CRP-TyG index (CTI) was composed of CRP and TyG. The concordance (C)-index, receiver operator characteristic (ROC) curve, and calibration curve reflected the prognostic predictive power of CTI. Univariate and multivariate survival analyses predicted the prognostic value of CTI in patients with cancer. Results: The C-indices of CTI in patients with cancer were 0.636, 0.617, and 0.631 in the total, training, and validation cohorts, respectively. The 1-, 3-, and 5-year ROC and calibration curves showed that CTI had a good predictive ability of survival in patients with cancer. Meanwhile, patients with high CTI had a worse prognosis compared to patients with low CTI (total cohort: hazard ratio [HR] = 1.46, 95% confidence interval [95% CI] = 1.33–1.59; training cohort: HR = 1.36, 95% CI = 1.22–1.52; validation cohort: HR = 1.73, 95% CI = 1.47–2.04]. Conclusion: The CTI is a useful prognostic indicator of poor prognosis and a promising tool for treatment strategy decision-making in patients with cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fendo.2022.905266

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Metadata

Authors
Ruan, G.-T., Xie, H.-L., Zhang, H.-Y., Liu, C.-A., Ge, Y.-Z., Zhang, Q., Wang, Z.-W., Zhang, X., Tang, M., Song, M.-M., Zhang, X.-W., Yang, M., Chen, Y.-B., Yu, K.-Y., Deng, L., Gong, Y.-Z., Hu, W., Wang, K.-H., Cong, M.-H., & Shi, H.-P.
Venue
Frontiers in Endocrinology
Published
2022-06-20
Volume
13
Pages
905266-905266
ISSN
1664-2392 (ISSN-L)
OpenAlex
W4283168116
Cited by
222
References
6
FWCI
7.88
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer. https://app.cochat.ai/papers/10.3389/fendo.2022.905266
The paper
Ruan, G.-T., Xie, H.-L., Zhang, H.-Y., Liu, C.-A., Ge, Y.-Z., Zhang, Q., Wang, Z.-W., Zhang, X., Tang, M., Song, M.-M., Zhang, X.-W., Yang, M., Chen, Y.-B., Yu, K.-Y., Deng, L., Gong, Y.-Z., Hu, W., Wang, K.-H., Cong, M.-H., & Shi, H.-P. (2022). A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2022.905266

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.